A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to bacille Calmette-Guérin (BCG) immunisation [ISRCTN32849447]

A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to bacille Calmette-Guérin (BCG) immunisation [ISRCTN32849447]

<p style="text-align:justify;"> <b>Background:</b> Maternal schistosomiasis and filariasis have been shown to influence infant responses to neonatal bacille Calmette-Guérin (BCG) immunisation but the effects of maternal hookworm, and of de-worming in pregnancy, are unkno...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Elliott, A, Namujju, P, Mawa, P, Quigley, M, Nampijja, M, Nkurunziza, P, Belisle, J, Muwanga, M, Whitworth, J
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	BioMed Central 2005

Míreanna comhchosúla

Tuberculosis vaccines: beyond bacille Calmette–Guérin
de réir: McShane, H
Foilsithe / Cruthaithe: (2011)

The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447].
de réir: Elliott, A, et al.
Foilsithe / Cruthaithe: (2007)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting
de réir: Dean, G, et al.
Foilsithe / Cruthaithe: (2014)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting.
de réir: Dean, G, et al.
Foilsithe / Cruthaithe: (2014)

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin.
de réir: Vordermeier, H, et al.
Foilsithe / Cruthaithe: (2004)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guérin
de réir: Minassian, A, et al.
Foilsithe / Cruthaithe: (2012)

Evaluation of the non-specific effects of Bacille Calmette-Guérin (BCG) vaccination in healthy UK adults
de réir: Wilkie, M
Foilsithe / Cruthaithe: (2019)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
de réir: Minassian, A, et al.
Foilsithe / Cruthaithe: (2012)

Optimization of a human bacille Calmette-Guerin challenge model: a tool to evaluate antimycobacterial immunity
de réir: Minhinnick, A, et al.
Foilsithe / Cruthaithe: (2015)

The impact of infant Bacille Calmette-Guérin vaccination on the immunogenicity of other vaccines: a randomized exploratory study
de réir: Maytum, A, et al.
Foilsithe / Cruthaithe: (2024)

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study
de réir: Fletcher, H, et al.
Foilsithe / Cruthaithe: (2016)

Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin.
de réir: Hope, J, et al.
Foilsithe / Cruthaithe: (2012)

Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin
de réir: Hope, J, et al.
Foilsithe / Cruthaithe: (2012)

Reactivation of the bacille Calmette-Guerin scar following immune reconstitution during treatment of infant acute lymphoblastic leukemia.
de réir: Swinson, S, et al.
Foilsithe / Cruthaithe: (2004)

Identification of N[superscript 6],N[superscript 6]-Dimethyladenosine in Transfer RNA from Mycobacterium bovis Bacille Calmette-Guérin
de réir: Chan, Tsz Yan Clement, et al.
Foilsithe / Cruthaithe: (2014)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
de réir: McShane, H
Foilsithe / Cruthaithe: (2011)

Using aerosol Bacille Calmette-Guérin in non-human primates to model the immune response to Mycobacterium Tuberculosis: a translational bridge between preclinical models and clinical trials
de réir: Hoogkamer, E
Foilsithe / Cruthaithe: (2022)

Implementation of universal newborn screening for severe combined immunodeficiency in Singapore while continuing routine Bacille-Calmette-Guerin vaccination given at birth
de réir: Chan, Bianca Su-Wan, et al.
Foilsithe / Cruthaithe: (2022)

Reiter's syndrome postintravesical Bacillus Calmette–Guérin instillations
de réir: Ng, K.L., et al.
Foilsithe / Cruthaithe: (2017)

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
de réir: Goonetilleke, N, et al.
Foilsithe / Cruthaithe: (2003)

Safety and immunogenicity of newborn MVA85A vaccination and selective, delayed Bacille Calmette-Guerin (BCG) for infants of HIV infected mothers: A phase 2 randomized controlled trial.
de réir: Nemes, E, et al.
Foilsithe / Cruthaithe: (2017)

Delaying bacillus Calmette-Guerin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.
de réir: Burl, S, et al.
Foilsithe / Cruthaithe: (2010)

Cloning, Expression And Immunogenicity Of Recombinant Bacille Calmette-Guerin (BCG) Containing T And B Cell Epitopes Of Mycobacterium Tuberculosis [QR82.M95 R737 2008 f rb].
de réir: Mohamud, Rohimah
Foilsithe / Cruthaithe: (2008)

Altered memory T-cell responses to Bacillus Calmette-Guerin and Tetanus Toxoid vaccination and altered cytokine responses to polyclonal stimulation in HIV-exposed uninfected Kenyan infants
de réir: Garcia-Knight, M, et al.
Foilsithe / Cruthaithe: (2015)

Hubungan kompetensi injeksi petugas imunisasi dengan hasil reaksi injeksi pasca imunisasi Bacillus calmette Guerin
de réir: , MADYANINGRUM, Ema, et al.
Foilsithe / Cruthaithe: (2006)

Identification of similar epitopes between SARS-CoV-2 and Bacillus Calmette-Guérin: potential for cross-reactive adaptive immunity
de réir: Urbán, Szabolcs, et al.
Foilsithe / Cruthaithe: (2020)

Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
de réir: Soleymani Majd, H
Foilsithe / Cruthaithe: (2022)

Guillain-Barré Syndrome following intravesical Bacillus Calmette-Guérin therapy for bladder cancer: a rare and intriguing case report
de réir: Khor, Vincent, et al.
Foilsithe / Cruthaithe: (2024)

Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination
de réir: Darboe, F, et al.
Foilsithe / Cruthaithe: (2017)

Safety and immunogenicity of early Bacillus Calmette-Guérin vaccination in infants who are preterm and/or have low birth weights. A systematic review and meta-analysis
de réir: Badurdeen, S, et al.
Foilsithe / Cruthaithe: (2018)

Novel pharmaceutical salts of albendazole
de réir: Bolla, Geetha, et al.
Foilsithe / Cruthaithe: (2018)

Onchocerciasis modulates the immune response to mycobacterial antigens.
de réir: Stewart, G, et al.
Foilsithe / Cruthaithe: (1999)

Pengaruh pemberian albendazol terhadap tikus bunting
de réir: , SARI, Puspa Wikan, et al.
Foilsithe / Cruthaithe: (1988)

Efektivitas salep Albendazol 2 persen dibanding tablet Albendazol pada pengobatan Cutaneous Larva Migrans
de réir: , ALAYDRUS, Aminah, et al.
Foilsithe / Cruthaithe: (2004)

Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression.
de réir: Hammond, A, et al.
Foilsithe / Cruthaithe: (2008)

Pengaruh pemberian albendazol terhadap tikus bunting
de réir: Perpustakaan UGM, i-lib
Foilsithe / Cruthaithe: (1988)

Nonphagocytic dendritic cells are effective accessory cells for anti-mycobacterial responses in vitro.
de réir: Kaye, P, et al.
Foilsithe / Cruthaithe: (1985)

Development Of Recombinant Mycobacterium Bovis Bacille Calmette Guerin (Rbcg) Expressing The 19 Kda C-Terminus Of Merozoite Surface Protein-1 (MSP-1C) And The 22kda Of Serine Repeat Antigen (SE22) Of Plasmodium Falciparum As A Potential Blood-Stage Malarial Vaccine [QR82.M8 N974 2008 f rb].
de réir: Abdullah, Nurul Asma
Foilsithe / Cruthaithe: (2008)

Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth
de réir: Fletcher, H, et al.
Foilsithe / Cruthaithe: (2009)

Detection of resistance of gastrointestinal nematodes to albendazole and ivermectin in goats
de réir: Hassan Basri, Basripuzi Nurul Hayyan, et al.
Foilsithe / Cruthaithe: (2010)